Not a member? Sign Up

Reasons for Joining

    Address your challenges through knowledge sharing with peers from our global network of specialists.

    Benchmark your business initiatives with the who's who in the field.

    Hear from industry pioneers how to maximize ROI in today's challenging economy.

    And best of all It's FREE!
Sign in using your existing
Pharma IQ account
Username or Email:

Sign Up    |  Already a member? Sign In
Pharma IQ

Breakthroughs in CRO Customer Service

This webinar will cover how FDA submissions can be simplified by having instant and full access to your data, 24*7 and benefitting from a CRO expertise while protecting your IP.


Presented By: Kelly L. Zaleski & Francois Beill
Date: February 23, 2012, 2:00 PM CET

3 Top Tips for Clinical Trial Supply in India

Gagan Bhradwaj, General Manager-Procurement & Supply Management, Zydus Cadila India, speaks about the main challenges for clinical trial supply in Asia now and how the industry is addressing these challenges throughout the supply chain


Author: Pharma IQ

The Big Pharma Recession Report 2012

Global Pharma Recession Study: 44.4 % worry their role will be made redundant within 12 months! To understand more about this alarming trend, read The Big Pharma Recession Report 2012.


Author: Pharma IQ
Date: January 2012

Access 6 hours of Direct Learning with Industry Expert John Trigg

No travel costs, no time out of the office, flexible learning for your whole team! Book before the 16th December for just $595.


Presented By: John Trigg
Date: Available from March 2012

Using Industry Spending Data to Develop Strategic Marketing

Big Pharma showed an increased need for bio-analytical testing, process optimization, stability storage and testing, cytotoxic projects and toxicology.


Author: Kate Hammeke

Key Considerations for Successful Niche and Orphan Drug Product Launches

Launching your drug product onto the European Market can present a real challenge if you are not familiar with country specific requirements. This webinar will clarify the key requirements for a successful EU product launch.


Presented By: Almac
Date: February 9 2012, 12:00 - 1.00 PM EST

Temperature Controlled Distribution Training

Access 5 sessions of direct learning with a leading industry expert to understand the increasing challenges of temperature sensitive supply chains.


Presented By: Laurent Foetisch
Date: Starts April 2012
Featured Content
Contributor: Kate Hammeke
Posted: 1/17/2012


Using Industry Spending Data to Develop Strategic Marketing - Kate Hammeke

When looking at overall spending for 2011 and projected outsourcing spend for 2012, one can determine which customer segments to target based on how the services offered by providers compare to the needs of each segment. Big Pharma showed an increased need for bio-analytical testing, process optimization, stability storage and testing, cytotoxic projects and toxicology.... Full Article »

Events related to this topic:
On Demand & Upcoming Webinars
  • EU Product Launch – Key Considerations for Successful Niche and Orphan Drug Product Launches Register Now »
  • From Produce to Patients: Improving Efficiency, Accountability and Accessibility Through Use of GS1 Standards Watch Now »
  • Exploring Challenges and Opportunities in Predictive Safety Tools: Trends from Industry-Wide Surveys Watch Now »
  • Serialization 2/0 - Getting Prepared for the Future of Pharma Supply Chain Security Watch Now »

How Can We Still Deliver an Effective Anti-Counterfeiting Program When Facing Cost Restraints?

Contributor: Pharma IQ
Posted: 1/27/2012


How Can We Still Deliver an Effective Anti-Counterfeiting Program When Facing Cost Restraints? - Pharma IQ

Cases of counterfeit pharmaceuticals being discovered entering the United States are on the up. Up 200 percent to $11 million (£7 million) in 2011 to be precise, based on the domestic value of seizures from the Customs and Border Protection (CBP) last year. Full Article »

Valea Video Series - Mechanics

Contributor:
Posted: 1/10/2012


Valea Video Series - Mechanics

100 years of experience in intellectual property rights Valea’s vision is to be regarded as one of Europe’s leading consulting firms in the field of intellectual property rights, and to be the natural choice for companies that work proactively to optimise the return on their intangible assets. Full Video »

Medicines Control Council's Enos Motshitela on the Importance of Temperature Mapping

Contributor: Pharma IQ
Posted: 1/27/2012


Medicines Control Council's Enos Motshitela on the Importance of Temperature Mapping

As the complexity of the vaccines and other temperature sensitive pharmaceutical supplies increases, it is very important to identify risks, challenges and their solutions across the end-to-end pharmaceutical supply chain. Enos Motshitela, Deputy Director: Inspectorate & Law Enforcement, Medicines Control Council, speaks about the importance of temperature mapping and overcoming the challenges of regulating vaccine distribution in South Africa. Full Podcast »

The Impact of Direct Nucleation Control on Crystal Size Distribution in Pharmaceutical Crystallization Processes

Posted: 1/25/2012

The Impact of Direct Nucleation Control on Crystal Size Distribution in Pharmaceutical Crystallization Processes

In this paper, a new direct nucleation control (DNC) approach is introduced that directly controls the apparent onset of nucleation defined as the formation of new particles with detectable size using in situ instruments. Full Whitepaper »


Advertisement

if yield deviation is occured then what will be corrective action and preventive ???????

Posted by:  itsmeasif.ali1986 | Answer this question

if yield deviation is occured then what will be corrective action and preventive ???????

Posted by:  itsmeasif.ali1986 | Answer this question

wHAT IS THE MEANING OF NORMALIZED IN Rrs testing ?

Posted by:  ddesai.398 | Answer this question

Hi What is the Job Profile of AREA BUSINESS MANAGER in PHARMA.

Posted by:  digvijay_singh24 | Answer this question

what is QA & QC Division In pharma .

Posted by:  amita25683 | Answer this question

How are GSK making leaps and strides in biopharma?

Posted by:  pharma_eye | Answer this question

wHAT IS THE MEANING OF NORMALIZED IN Rrs testing ?

Posted by:  ddesai.398 | Answer this question

Is there any color codes for pilpe lines in manufacturing area of a pharma company as per FDA requirement?

Posted by:  Madhav.settipalli@trianz.com | Answer this question

which institutes or company's provide training in biotechnology in mumbai

Posted by:  flavovaz | Answer this question

Advertisement


Andrea Charles

Andrea Charles

 
About Pharma IQ

Pharma IQ, a division of IQPC, is an international online community focusing on providing pharmaceutical and biotechnology professionals with knowledge, information and biotechnology articles. We are dedicated to creating a learning environment for sharing ideas, best practices and solutions within the pharmaceutical and biotech community.

Through Pharma IQ, you will be able to access pharmaceutical information resources such as biotechnology presentations and pharmaceutical podcasts, as well as events such as webinars, seminars and conferences.

By signing up to the Pharma IQ membership, you will gain access to our growing database of multimedia presentations from leading pharma and biotech practitioners, weekly newsletters to keep you updated on latest pharmaceutical content and Pharma IQ members-exclusive discounts on pharmaceutical events that offer solutions to your everyday business problems.

Pharma IQ and IQPC provide useful training courses, conference and expositions for pharmaceutical and biotech executives to network and learn the latest pharma business development and trends occurring in organizations today. Pharma IQ focuses on establishing an interactive experience featuring practical, objective and up-to-date insight from pharma and biotech industry leaders.